PHARPharming Group N.V.

11.85USDMkt Cap: 838.72M $P/E: 84.64

Pharming Group N.V., a biopharmaceutical company, develops and commercializes protein replacement therapies and precision medicines for the treatment of rare diseases in the United States, Europe, and internationally. Th…

Key Statistics

Company
Market Cap838.72M $
Enterprise Value781.70M $
Revenue (TTM)366.48M $
Gross Profit330.63M $
Net Income (TTM)2.85M $
Revenue/Share5.220 USD
Last Price11.85 USD
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees407
CountryUS
SectorHealthcare
IndustryBiotechnology
ISINNL0010391025
Valuation
P/E (Trailing)84.64
P/E (Forward)38.05
PEG
EV/EBITDA23.77
EV/Revenue2.13
P/S2.26
P/B3.06
EPS (TTM)0.14
EPS (Forward)0.31
52W Range
11.7350% of range11.97
52W High11.97 USD
52W Low11.73 USD
Profitability
Gross Margin87.90%
Oper. Margin1.46%
EBITDA Margin8.97%
Profit Margin0.76%
ROE1.03%
ROA0.57%
Growth
Revenue Growth-3.20%
Earnings Growth-62.90%
Cash Flow & Leverage
Operating CF54.71M $
CapEx (TTM)755.00K $
FCF Margin10.28%
FCF Yield4.49%
Net Debt-44.99M $
Net Debt/EBITDA-1.37
Balance Sheet
Debt/Equity0.42
Current Ratio3.01
Quick Ratio2.31
Book Value/Sh3.820 USD
Cash/Share2.236 USD
Dividends
Fwd Div Rate
Trail. Div Rate0.0000 USD
Div. Yield
5Y Avg Yield
Payout Ratio0.00%
Ex-Div Date
Pay Date
Analyst Consensus
Rating
Target (Mean)34.35 USD
Upside (mean)+189.9%
Target Range23.40 USD39.00 USD
$23.40+189.9% to mean$39.00
# Analysts4
Ownership
Shares Out.70.78M
Float69.66M
Insiders0.00%
Institutions0.14%
Short Interest
Short Ratio2.2d
Short % Float0.03%
Short % Out.0.03%
Shares Short19.18K
Short (prev mo.)3.20K
Technical
SMA 5012.62 (-6.1%)
SMA 20015.31 (-22.6%)
Beta0.06
S&P 52W Chg21.00%
Avg Vol (30d)10.88K
Avg Vol (10d)31.08K
Technical Indicators
RSI (14)48.5
MACD-0.2137
MACD Signal-0.3404
MACD Hist.+0.1268
BB Upper13.25 USD
BB Middle11.49 USD
BB Lower9.732 USD
BB Width30.62%
ATR (14)0.6270 USD
Vol Ratio (20d)0.46x